Lista de obras -

An open clinical trial of reboxetine in the treatment of social phobia

artículo científico publicado en 2003

Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder

artículo científico publicado en 2002

Antioxidant enzyme and malondialdehyde levels in patients with panic disorder

artículo científico publicado en 2002

Antioxidant enzyme and malondialdehyde levels in patients with social phobia

artículo científico publicado en 2008

Arnold-Chiari I malformation association with generalized anxiety disorder: a case report.

artículo científico publicado en 2008

Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature

artículo científico publicado en 2010

Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome

artículo científico publicado en 2015

Dissociative disorders in Turkish inpatients with conversion disorder

artículo científico publicado en 2003

Eating disorders and food addiction in men with heroin use disorder: a controlled study

artículo científico publicado en 2017

Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings

artículo científico publicado en 2002

Free radicals in patients with post-traumatic stress disorder

artículo científico publicado en 2003

High serum leptin levels in depressive disorders with atypical features

artículo científico publicado en 2005

Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

artículo científico publicado en 2016

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

artículo científico publicado en 2002

Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder

artículo científico publicado en 2002

Neopterin production in posttraumatic stress disorder before and after pharmacotherapy

artículo científico publicado en 2003

Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia

artículo científico publicado en 2015

Nizatidine for the treatment of patients with quetiapine-induced weight gain

artículo científico publicado en 2004

Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain

artículo científico publicado en 2003

Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol

artículo científico publicado en 2002

Quetiapine-associated and dose-related hypomania in a woman with schizophrenia

artículo científico publicado en 2002

Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo

artículo científico publicado en 2014

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine

artículo científico publicado en 2013

Serum folate and homocysteine levels in patients with obsessive-compulsive disorder

artículo científico publicado en 2005

Serum iron levels in schizophrenic patients with or without akathisia.

artículo científico publicado en 2003

Serum leptin and cholesterol levels in patients with bipolar disorder

artículo científico publicado en 2002

Serum leptin and cholesterol values in suicide attempters

artículo científico publicado en 2002

Serum leptin and cholesterol values in violent and non-violent suicide attempters

artículo científico publicado en 2007

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

artículo científico publicado en 2003

Serum leptin levels in obsessive-compulsive disorder

artículo científico publicado en 2005

Switching to tianeptine in patients with antidepressant-induced sexual dysfunction

artículo científico publicado en 2003

The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia

artículo científico publicado en 2005

Weight gain and serum leptin levels in patients on lithium treatment

artículo científico publicado en 2002

Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol

artículo científico publicado en 2003

Lista de obras de

An open clinical trial of reboxetine in the treatment of social phobia

Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder

Antioxidant enzyme and malondialdehyde levels in patients with panic disorder

Antioxidant enzyme and malondialdehyde levels in patients with social phobia

Arnold-Chiari I malformation association with generalized anxiety disorder: a case report.

Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature

Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome

Dissociative disorders in Turkish inpatients with conversion disorder

Eating disorders and food addiction in men with heroin use disorder: a controlled study

Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings

Free radicals in patients with post-traumatic stress disorder

High serum leptin levels in depressive disorders with atypical features

Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder

Neopterin production in posttraumatic stress disorder before and after pharmacotherapy

Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia

Nizatidine for the treatment of patients with quetiapine-induced weight gain

Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain

Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol

Quetiapine-associated and dose-related hypomania in a woman with schizophrenia

Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine

Serum folate and homocysteine levels in patients with obsessive-compulsive disorder

Serum iron levels in schizophrenic patients with or without akathisia.

Serum leptin and cholesterol levels in patients with bipolar disorder

Serum leptin and cholesterol values in suicide attempters

Serum leptin and cholesterol values in violent and non-violent suicide attempters

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Serum leptin levels in obsessive-compulsive disorder

Switching to tianeptine in patients with antidepressant-induced sexual dysfunction

The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia

Weight gain and serum leptin levels in patients on lithium treatment

Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol